Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)


Wir halten Sie auf dem Laufenden! Wenn Sie Fragen zu unseren Pressemitteilungen haben, können Sie uns gerne über das Kontaktformular der Website kontaktieren. Bleiben Sie über die neuesten Nachrichten unseres Unternehmens auf dem Laufenden:

Eckert & Ziegler BEBIG announces the launch of SagiNova® and SagiPlan® for HDR brachytherapy

Seneffe, Belgium, April 23rd, 2015. Eckert & Ziegler BEBIG is proud to announce the global launch of its new afterloader SagiNova® and the corresponding treatment planning system SagiPlan® at the 3rd ESTRO Forum in Barcelona, Spain.

SagiNova® is derived from the latin words 'Sagitta' and 'novum' which mean arrow and new. With SagiNova®, Eckert & Ziegler BEBIG offers the most modern HDR afterloader with precise, arrow-like targeting. "It is our ambition to incorporate customer needs into product development. The newest technology inside fulfills today's global customer demands regarding safety, seamless workflows, and cost efficiency as well as regulatory demands; it also builds a platform for further development," says Abel Luzuriaga, Managing Director of Eckert & Ziegler BEBIG.

SagiNova® incorporates the outstanding features of the MultiSource® afterloader such as the choice between a cobalt-60 and iridium-192 source, the integrated In-Vivo Dosimetry System, automatic path length measurement and digital source position verification. A new hardware and software platform allows for new features like the highly customizable tool QAssist that supports users in a straightforward way to adhere to the highest quality assurance standards with full digital documentation. It offers pre-defined quality assurance tests which verify whether the system and critical components are operating correctly. QAssist configurations can be shared with partnering departments to allow for consistent quality reporting. 

The remote support implemented with SagiNova® allows for short response times and enhanced service support. Additionally, the 40 channel support of MultiSource® was refined to 50 channel support in SagiNova®.

The new SagiNova® and SagiPlan® graphical user interfaces (GUI) were developed in cooperation with brachytherapy experts and usability engineers leading to the development of the next level of smooth and efficient workflow guidance. Besides the new intuitive and modern GUI, SagiPlan® includes an improved prostate module regarding image registration and treatment visualization features. Additionally, a needle placement helper was introduced with automatic needle labeling and channel template assignment report was added together with many other features to allow for an improved workflow.

SagiNova® and SagiPlan® have CE mark. 510(k) for SagiNova® was obtained recently which enables Eckert & Ziegler BEBIG to expand into the U.S. brachytherapy market with an estimated 2,400 radiation therapy centers. For any further requests, please contact your local Eckert & Ziegler BEBIG representative or visit us on ESTRO booth #1500 from April 24th to April 27th, 2015!


About Eckert & Ziegler BEBIG
Contributing to saving lives!

Eckert & Ziegler BEBIG is a global provider of radiotherapy products and a brachytherapy leader in Europe. The company's offices and subsidiaries are located in Belgium, Germany, France, Spain, UK, Italy, the USA, Brazil and India. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line.

Eckert & Ziegler BEBIG is dynamically growing company and employs currently more than 200 people all over the globe. With its' annual turnover of about 30 million Euro the company pursues a strategy of continuous market expansion and permanent improvement of its product portfolio to support optimally the fight against cancer.

Eckert & Ziegler BEBIG has been listed on the Euronext stock exchange since April 1997.

Claudia Wolf
Head of Marketing
Tel: +49 30 94 10 84 272